NCT07214831

Brief Summary

American emerging adults (EAs; aged 18-29 years) have the highest rates of alcohol use disorder (AUD) and the lowest levels of treatment engagement of any age group. Innovative, scalable, and cost-effective strategies are needed to expand early detection and intervention for EAs engaged in patterns of drinking associated with AUD. Because digital technology use is frequent among EAs, digital interventions may be a particularly suitable way to reach this population. Prior studies of digital alcohol interventions demonstrate modest but consistent reductions in alcohol use, but these tools are often limited by a lack of interactivity and personalization. Large language model (LLM)-based chatbots, such as ChatGPT, may address these limitations by enabling personalized, adaptive, and human-like engagement. These features have the potential to increase uptake and engagement with screening and brief interventions among EAs. This study will develop, validate, and conduct an open trial of an LLM-based chatbot-delivered brief intervention designed to reduce alcohol use and problems among EAs, with the primary goal of establishing preliminary feasibility and acceptability.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
15mo left

Started Jun 2027

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 9, 2025

Completed
1.6 years until next milestone

Study Start

First participant enrolled

June 1, 2027

Expected
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2028

Last Updated

October 22, 2025

Status Verified

October 1, 2025

Enrollment Period

7 months

First QC Date

October 6, 2025

Last Update Submit

October 20, 2025

Conditions

Outcome Measures

Primary Outcomes (7)

  • Time to achieve target enrollment

    Recruitment feasibility will be evaluated based on the length of time needed to recruit target enrollment (N = 20)

    Enrollment

  • Rate of participant retention

    Retention feasibility will be achieved if \>80% of participants who consented to participating in the study complete one-month follow-up assessment.

    1-month post intervention1-month post intervention

  • Acceptability (System Usability Scale)

    Acceptability of the conversational agent-delivered intervention will be measured using the 10-item System Usability Scale. Each question is rated on a Likert-type scale ranging from (1) strongly disagree to (5) strongly agree.

    Immediate post-intervention session

  • Acceptability - intervention delivery method

    Percentage of participants who agree or strongly agree the intervention delivery method was acceptable

    Immediate post-intervention session

  • Acceptability - usable

    Percentage of participants who agree or strongly agree the intervention was easy to interact with

    Immediate post-intervention session

  • Acceptability - helpful

    Percentage of participants who agree or strongly agree the intervention was helpful

    Immediate post-intervention session

  • Acceptability - recommend to others

    Percentage of participants who agree or strongly agree they would recommend the chatbot to others

    Immediate post-intervention session

Secondary Outcomes (6)

  • Motivation to change drinking (Readiness Ruler)

    Enrollment, immediate post-intervention session, and 1 month post-intervention

  • Daily drinking questionnaire (DDQ)

    Enrollment and 1 month post-intervention

  • Alcohol Use Disorders Identification Test (AUDIT)

    Enrollment and 1 month post-intervention

  • Young Adult Alcohol Consequences Questionnaire (YAACQ)

    Enrollment and 1 month post-intervention

  • Protective behavioral strategies scale (PBSS)

    Enrollment and 1 month post-intervention

  • +1 more secondary outcomes

Study Arms (1)

Large language model-based chatbot brief alcohol intervention

EXPERIMENTAL

All participants will interact with a large language model-based chatbot designed to deliver a brief alcohol intervention session.

Behavioral: Large language model-based chatbot brief alcohol intervention session

Interventions

The intervention is a large language model-based chatbot designed to delivered brief alcohol interventions using motivational interviewing-consistent strategies. The chatbot session will last approximately 45 minutes and will include a decisional balance exercise, feedback on drinking patterns, normative beliefs about drinking, alcohol-related consequences, goal setting, and harm-reduction strategies.

Large language model-based chatbot brief alcohol intervention

Eligibility Criteria

Age18 Years - 29 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years old
  • Engaged in past-month hazardous drinking (consuming ≥ 5/4 drinks for men/women on two or more occasions in the past month) or exceeded recommended guidelines for risky drinking (\> 14/7 drinks per week for men/women)
  • Able to read and comprehend English at a 5th grade level

You may not qualify if:

  • Report a history of or active psychosis
  • Previous or current engagement in alcohol or drug treatment
  • Risk for alcohol withdrawal as evidenced by very heavy weekly drinking reports on the alcohol screener (\> 40 standard drinks in a typical week in the past month)
  • Demonstrate inability or unwillingness to attend in-person office visits
  • Demonstrate inability or unwillingness to identify an emergency contact who could be contacted in case the participant becomes lost to follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

Alcoholism

Interventions

Ethanol

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Study Officials

  • Alex M Russell, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alex M Russell, PhD

CONTACT

Samuel F Acuff, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Psychiatry

Study Record Dates

First Submitted

October 6, 2025

First Posted

October 9, 2025

Study Start (Estimated)

June 1, 2027

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

August 31, 2028

Last Updated

October 22, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

De-identified data will be submitted to the NIAAA Data Archive in accordance with NIH requirements.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
De-identified individual participant data (IPD) and supporting documents will be deposited in the NIAAA Data Archive (NIAAADA) hosted within the NIMH Data Archive. Data will be submitted within 6 months of collection and will be available after study completion, in perpetuity.
Access Criteria
Data will be de-identified and available as public use data through the NIAAA Data Archive. Access requires submission of a data use request through the NIAAADA and agreement to the Terms of Use, which limit use to scientific research, prohibit attempts to identify participants, and require reporting of any breaches of confidentiality.
More information

Locations